196 related articles for article (PubMed ID: 29432207)
1. Prevalence of comorbid conditions pre-existing and diagnosed at a tertiary care pediatric weight management clinic.
Leon G; de Klerk E; Ho J; Jackman M; Reimer RA; Connors KE; Luca P
J Pediatr Endocrinol Metab; 2018 Mar; 31(4):385-390. PubMed ID: 29432207
[TBL] [Abstract][Full Text] [Related]
2. Children's Hospital Association consensus statements for comorbidities of childhood obesity.
Estrada E; Eneli I; Hampl S; Mietus-Snyder M; Mirza N; Rhodes E; Sweeney B; Tinajero-Deck L; Woolford SJ; Pont SJ;
Child Obes; 2014 Aug; 10(4):304-17. PubMed ID: 25019404
[TBL] [Abstract][Full Text] [Related]
3. Re: Estrada et al., "Children's Hospital Association Consensus Statements for Comorbidities of Childhood Obesity".
Scheimann AO; Abrams SH
Child Obes; 2015 Jun; 11(3):231-2. PubMed ID: 26034812
[No Abstract] [Full Text] [Related]
4. Epidemiology and comorbidities of polycystic ovary syndrome in an indigent population.
Sirmans SM; Parish RC; Blake S; Wang X
J Investig Med; 2014 Aug; 62(6):868-74. PubMed ID: 24844662
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease.
Newton KP; Hou J; Crimmins NA; Lavine JE; Barlow SE; Xanthakos SA; Africa J; Behling C; Donithan M; Clark JM; Schwimmer JB;
JAMA Pediatr; 2016 Oct; 170(10):e161971. PubMed ID: 27478956
[TBL] [Abstract][Full Text] [Related]
6. Association of Psoriasis With Comorbidity Development in Children With Psoriasis.
Tollefson MM; Van Houten HK; Asante D; Yao X; Maradit Kremers H
JAMA Dermatol; 2018 Mar; 154(3):286-292. PubMed ID: 29322175
[TBL] [Abstract][Full Text] [Related]
7. Increased Prevalence of Severe Obesity and Related Comorbidities among Patients Referred to a Pediatric Obesity Clinic during the Last Decade.
Avnieli Velfer Y; Phillip M; Shalitin S
Horm Res Paediatr; 2019; 92(3):169-178. PubMed ID: 31805573
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, pathogenesis and management of prediabetes and type 2 diabetes mellitus in patients with polycystic ovary syndrome.
Lazaridou S; Dinas K; Tziomalos K
Hormones (Athens); 2017 Oct; 16(4):373-380. PubMed ID: 29518757
[TBL] [Abstract][Full Text] [Related]
9. Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity.
Mohamed RZ; Jalaludin MY; Anuar Zaini A
J Pediatr Endocrinol Metab; 2020 Feb; 33(2):247-253. PubMed ID: 31926095
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Consequences of Pediatric Obesity: A Review of Pathophysiology, Screening, and Treatment.
Gunaratne N; Deplewski D
Pediatr Ann; 2023 Feb; 52(2):e62-e67. PubMed ID: 36779885
[TBL] [Abstract][Full Text] [Related]
11. Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over.
Ryan DH; Yockey SR
Curr Obes Rep; 2017 Jun; 6(2):187-194. PubMed ID: 28455679
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome.
Glintborg D; Rubin KH; Nybo M; Abrahamsen B; Andersen M
Cardiovasc Diabetol; 2018 Mar; 17(1):37. PubMed ID: 29519249
[TBL] [Abstract][Full Text] [Related]
13. Exploring the Prevalence of Undiagnosed Prediabetes, Type 2 Diabetes Mellitus, and Risk Factors in Adolescents: A Systematic Review.
Spurr S; Bally J; Hill P; Gray K; Newman P; Hutton A
J Pediatr Nurs; 2020; 50():94-104. PubMed ID: 31786470
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Insulin Resistance with Anthropometric and Clinical Laboratory Measures in Nondiabetic Teenagers.
Choi YS; Klaric JS; Beltran TH
Metab Syndr Relat Disord; 2019 Feb; 17(1):37-45. PubMed ID: 30394863
[TBL] [Abstract][Full Text] [Related]
15. Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome.
Asfari MM; Sarmini MT; Baidoun F; Al-Khadra Y; Ezzaizi Y; Dasarathy S; McCullough A
BMJ Open Gastroenterol; 2020 Aug; 7(1):. PubMed ID: 32784205
[TBL] [Abstract][Full Text] [Related]
16. Retrospective Review of Comorbid Conditions in a Multidisciplinary Pediatric Weight Management Clinic.
Thang C; Whitley M; Izadpanah N; DeUgarte D; Slusser W
Clin Pediatr (Phila); 2018 Jun; 57(7):815-820. PubMed ID: 28990428
[TBL] [Abstract][Full Text] [Related]
17. Non-Alcoholic Fatty Liver Disease in Cuba.
Castellanos-Fernández MI; Crespo-Ramírez E; Del Valle-Díaz S; Barreto-Suárez E; Díaz-Elías JO; Corrales-Alonso S; Morales-Martínez L; Morales-Martínez I; Cedeño-Ramírez E; Pérez-González T; González-Suero SM; Ruenes-Domech C; Infante-Velázquez M; Borges-González SA; Elvírez-Gutiérrez A; Lazo-Del Vallín S; Villa-Jiménez OM; Labrada-Moreno LM
MEDICC Rev; 2021 Jan; 23(1):64-71. PubMed ID: 33780425
[TBL] [Abstract][Full Text] [Related]
18. Metabolic risk factors in adolescent girls with type 1 diabetes.
Castro-Correia C; Santos-Silva R; Pinheiro M; Costa C; Fontoura M
J Pediatr Endocrinol Metab; 2018 Jun; 31(6):631-635. PubMed ID: 29750655
[TBL] [Abstract][Full Text] [Related]
19. Screening for metabolic and reproductive complications in obese children and adolescents.
Irizarry KA; Brito V; Freemark M
Pediatr Ann; 2014 Sep; 43(9):e210-7. PubMed ID: 25198445
[TBL] [Abstract][Full Text] [Related]
20. Comorbidities in overweight children and adolescents: do we treat them effectively?
Reinehr T; Wiegand S; Siegfried W; Keller KM; Widhalm K; l'Allemand D; Zwiauer K; Holl RW
Int J Obes (Lond); 2013 Apr; 37(4):493-9. PubMed ID: 23147116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
